Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease

Nature Genetics

Volumn 41, Issue 12, 2009, Pages 1341-1344

  McCarroll, Steven A ^a,b,c   Bradner, James E ^c,d   Turpeinen, Hannu ^e   Volin, Liisa ^f   Martin, Paul J ^g,h   Chilewski, Shannon D ^c   Antin, Joseph H ^d   Lee, Stephanie J ^d,g   Ruutu, Tapani ^f   Storer, Barry ^g   Warren, Edus H ^g,h   Zhang, Bo ^g   Zhao, Lue Ping ^g   Ginsburg, David ⁱ   Soiffer, Robert J ^d   Partanen, Jukka ^e   Hansen, John A ^g,h   Ritz, Jerome ^d   Palotie, Aarno ^c,j,k   Altshuler, David ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e FINNISH RED CROSS BLOOD SERVICE   (Finland)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g Fred Hutchinson Cancer Research Center   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

^j UNIVERSITY OF HELSINKI   (Finland)

^k WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HISTOCOMPATIBILITY ANTIGEN;

ALLOIMMUNITY; ARTICLE; BONE MARROW TRANSPLANTATION; CONFIDENCE INTERVAL; DONOR SELECTION; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENETIC POLYMORPHISM; GENOME; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SIBLING; UGT2B17 GENE;

BONE MARROW TRANSPLANTATION; COHORT STUDIES; FEMALE; GENE DELETION; GENOME, HUMAN; GLUCURONOSYLTRANSFERASE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; MALE; POLYMORPHISM, GENETIC;

EID: 70549083243     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.490     Document Type: Article

References (32)

1. Gale, R.P. & Champlin, R.E. How does bone-marrow transplantation cure leukaemia? Lancet 2, 28-30 (1984).
2. Gale, R.P. et al. Identical-twin bone marrow transplants for leukemia. Ann. Intern. Med. 120, 646-652 (1994).
3. Randolph, S.S., Gooley, T.A., Warren, E.H., Appelbaum, F.R. & Riddell, S.R. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 103, 347-352 (2004).
4. Wang, W. et al. Human H-Y: a male-specifc histocompatibility antigen derived from the SMCY protein. Science 269, 1588-1590 (1995).
5. Meadows, L. et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modifed cysteine that signifcantly affects T cell recognition. Immunity 6, 273-281 (1997).
6. Warren, E.H. et al. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J. Immunol. 164, 2807-2814 (2000).
7. Vogt, M.H. et al. The DBY gene codes for an HLA-DQ5-restricted human male-specifc minor histocompatibility antigen involved in graft-versus-host disease. Blood 99, 3027-3032 (2002).
8. Spierings, E. et al. Identifcation of HLA class II-restricted H-Y-specifc T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet 362, 610-615 (2003).
9. Ivanov, R. et al. Identifcation of a 40S ribosomal protein S4-derived H-Y epitope able to elicit a lymphoblast-specifc cytotoxic T lymphocyte response. Clin. Cancer Res. 11, 1694-1703 (2005).
10. Skaletsky, H. et al. The male-specifc region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 423, 825-837 (2003).
11. Sebat, J. et al. Large-scale copy number polymorphism in the human genome. Science 305, 525-528 (2004).
12. Iafrate, A.J. et al. Detection of large-scale variation in the human genome. Nat. Genet. 36, 949-951 (2004).
13. McCarroll, S.A. et al. Common deletion polymorphisms in the human genome. Nat. Genet. 38, 86-92 (2006).
14. Conrad, D.F., Andrews, T.D., Carter, N.P., Hurles, M.E. & Pritchard, J.K. A high-resolution survey of deletion polymorphism in the human genome. Nat. Genet. 38, 75-81 (2006).
15. Colin, Y. et al. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 78, 2747-2752 (1991).
16. Murata, M., Warren, E.H. & Riddell, S.R. A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J. Exp. Med. 197, 1279-1289 (2003).
17. McCarroll, S.A. et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat. Genet. 40, 1166-1174 (2008).
18. Schulze, J.J. et al. Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation. J. Clin. Endocrinol. Metab. 93, 2500-2506 (2008).
19. Terakura, S. et al. A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantation. Br. J. Haematol. 129, 221-228 (2005).
20. Yang, T.L. et al. Genome-wide copy-number-variation study identifed a susceptibility gene, UGT2B17, for osteoporosis. Am. J. Hum. Genet. 83, 663-674 (2008).
21. Terakura, S. et al. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and-B*4403. Transplantation 83, 1242-1248 (2007).
22. Kamei, M. et al. HapMap scanning of novel human minor histocompatibility antigens. Blood 113, 5041-5048 (2009).
23. Miklos, D.B. et al. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood 103, 353-359 (2004).
24. Miklos, D.B. et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 105, 2973-2978 (2005).
25. Zorn, E. et al. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J. Exp. Med. 199, 1133-1142 (2004). (Pubitemid 38619909)
26. Cutler, C. et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 108, 756-762 (2006). (Pubitemid 44061381)
27. Xue, Y. et al. Adaptive evolution of UGT2B17 copy-number variation. Am. J. Hum. Genet. 83, 337-346 (2008).
28. Petersdorf, E.W., Malkki, M., Gooley, T.A., Martin, P.J. & Guo, Z. MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Med. 4, e8 (2007).
29. Martin, P.J. et al. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 10, 320-327 (2004).
30. Nichols, W.C. et al. Polymorphism of adhesion molecule CD31 is not a signifcant risk factor for graft-versus-host disease. Blood 88, 4429-4434 (1996).
31. International HapMap Consortium. A haplotype map of the human genome. Nature 327, 1299-1320 (2005).
32. Korn, J.M. et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat. Genet. 40, 1253-1260 (2008).